Roche Holding AG (ROP.SW)

Swiss · Healthcare · Drug Manufacturers - General
396.80 CHF-0.60%As of 2026-11-22 · CHF
Last session low 395.20 CHFLast session high 401.20 CHF
52-week low 291.00 CHF52-week high 410.90 CHF
Market cap (USD)
$376.58B
Sector
Healthcare
P/E (TTM)
25.9x
Dividend yield
2.47%
Next earnings
2027-01-28

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in CHF.

IndicatorValueReading
RSI (14)53.4In the neutral range (30 to 70)
MACD (12, 26, 9)6.60Below its signal line (8.07); histogram -1.47
Bollinger %B (20, 2)37%Inside the bands (388.88 to 410.03)
SMA 20399.46Price is 0.7% below
SMA 50378.21Price is 4.9% above
SMA 200346.32Price is 14.6% above
ATR (20)1.76% of priceAverage true range per day
52-week position88%In the upper part of the 291.00 to 410.90 range

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Latest fiscal yearEnded 2025-12-31: revenue of 63.36B CHF and an operating margin of 29.2%.
Next earnings reportExpected on 2027-01-28.

Also listed as RO.SW (Swiss)

More in Drug Manufacturers - General